Abstract 1788: Increasing the therapeutic index of IL12 by engineering for tumor specific protease activation

Author(s):  
Jennifer Leah Bishop ◽  
Ryan Blackler ◽  
Gesa Volkers ◽  
Maya Poffenberger ◽  
Irene Yu ◽  
...  
Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 3133-3133
Author(s):  
Melanie Clark ◽  
Nasir Sadeghi ◽  
Debra Hoppensteadt ◽  
Lauren Myers ◽  
Vinod Bansal ◽  
...  

Abstract Abstract 3133 Poster Board III-70 The main contaminant in heparins recalled by the FDA in 2008 was reported to be oversulfated chondroitin sulfate (OSCS) (Kishimoto et al 2008). The adverse reactions were reportedly linked to contact activation and the generation of kallikrein. Because of the molecular and biologic heterogeneity of the contaminants isolated from heparin and LMWHs and the potential presence of other carryover contaminants it was hypothesized that heparin contaminants may also activate other proteases such as plasmin, C1 esterase factor Xa (FXa), and thrombin by direct or indirect mechanisms. To investigate the protease activation profile of heparin, porcine chondroitin sulfate (PCS) and OSCS preparations of porcine (POSCS), bovine (BOSCS) shark (SOCS) and squid (SqOSCS) origin along with contaminants isolated from five different recalled batches of heparin were profiled for the generation of kallikrein, plasmin, C1 esterase, FXa, and thrombin. Normal human pooled plasma (NHP) was supplemented with each of the different agents over a concentration range of 100ug/ml to 0.1ug/ml. Specific substrates for kallikrein (Chromozyme PK), plasmin (Chromozyme PL), C1 esterase (S2302), FXa (Chromozyme Xa), and thrombin (Chromozyme Th) were used to measure the generation of specific enzymes. The PCS produced relatively weaker generation of kallikrein, however, the contaminants isolated from the recalled batches of heparin produced a much stronger generation of this enzyme (absorbance 0.45-0.70). The different OSCS preparations produced a lower generation of kallikrein (absorbance .34-.52). While heparin and PCS produced significant activation of C1 esterase, the contaminants produced an even stronger activation of C1 esterase (abs .33-.44). The OSCS preparations from different sources produce relatively weaker activation which was comparable to the starting material. The C1 esterase activation profile was not proportional to the kallikrein activation. The PCS, UFH, and contaminants along with the different OSCS preparations produced varying degrees of plasmin generation. UFH and PCS also produced significant generation of plasmin which was higher than their C1 esterase and prekallikrein generation. With the exception of PCS and UFH, all of the agents produced varying degrees of Xa and thrombin generation. The generation of Xa was higher by all of the OSCS preparations in comparison to the IIa generation. Interestingly each of the OSCS preparations and different contaminants exhibited their own specific protease generation profile. There was no correlation between the kallikrein formation and the generation of other enzymes. These data highly suggest that the molecular composition of OSCS's and the contaminants play a major role in the mediation of the pathophysiologic responses observed with the use of contaminated heparin. The presence of other glycosaminoglycans may influence the protease generation profile of contaminants present in recalled heparins. Moreover, the relative generation of these proteases may also be influenced by the pathologic predisposition of patients where the generation of these proteases may influence the overall pathophysiologic response. Disclosures No relevant conflicts of interest to declare.


Author(s):  
E. H. Egelman ◽  
X. Yu

The RecA protein of E. coli has been shown to mediate genetic recombination, regulate its own synthesis, control the expression of other genes, act as a specific protease, form a helical polymer and have an ATPase activity, among other observed properties. The unusual filament formed by the RecA protein on DNA has not previously been shown to exist outside of bacteria. Within this filament, the 36 Å pitch of B-form DNA is extended to about 95 Å, the pitch of the RecA helix. We have now establishedthat similar nucleo-protein complexes are formed by bacteriophage and yeast proteins, and availableevidence suggests that this structure is universal across all of biology, including humans. Thus, understanding the function of the RecA protein will reveal basic mechanisms, in existence inall organisms, that are at the foundation of general genetic recombination and repair.Recombination at this moment is assuming an importance far greater than just pure biology. The association between chromosomal rearrangements and neoplasms has become stronger and stronger, and these rearrangements are most likely products of the recombinatory apparatus of the normal cell. Further, damage to DNA appears to be a major cause of cancer.


1995 ◽  
Vol 73 (03) ◽  
pp. 488-494 ◽  
Author(s):  
J L M Heeremans ◽  
R Prevost ◽  
M E A Bekkers ◽  
P Los ◽  
J J Emeis ◽  
...  

SummaryIn this study, we aimed at improving the therapeutic index of tissue- type Plasminogen Activator (t-PA) as thrombolytic agent in the treatment of myocardial infarction. Liposome-encapsulated t-PA was tested in a rabbit jugular vein thrombosis model: administration of free t-PA (t-PA) as a bolus injection in the ear vein was compared to a similar administration of liposomal t-PA (t-PA-lip), liposomal t-PA in plasminogen-coated liposomes (Plg-t-PA-lip), a mixture of free t-PA and empty liposomes (t-PA+empty lip) and a saline-blank (blank) in terms of thrombolytic activity and side effects.Liposomal t-PA (t-PA-lip/Plg-t-PA-lip) showed a significantly better thrombolysis efficiency than equimolar doses of free t-PA (t-PA/ t-PA+ empty lip): about 0.24 mg/kg of liposomal t-PA practically equalled the lysis-activity of a dose of free t-PA of 1.0 mg/kg (t-PAlmg/kg). On the other hand, liposome encapsulation did not affect the systemic activation of alpha2-antiplasmin and plasminogen by t-PA.We conclude that for this model an improvement in thrombolytic efficacy of t-PA is achieved by liposome encapsulation of t-PA. As t-PA-lip and Plg-t-PA-lip -treatment induced similar results, targeting of liposomal t-PA by coupled glu-Plg remains a topic to be optimized in future studies.


Author(s):  
Luis Gustavo Perez Rivas ◽  
Marily Theodoropoulou ◽  
Francesco Ferrau ◽  
Clara Nusser ◽  
Kohei Kawaguchi ◽  
...  

Author(s):  
Elnaz Asgharkhani ◽  
Aazam Najmafshar ◽  
Mohsen Chiani

This study aims to investigate the effects of different non-ionic surfactants on physicochemical properties of ART niosomes. ART is a natural compound that is used as an antimalarial and chemotherapy agent in medicine. ART has low bioavailability, stability and solubility. In order to solve these problems and enhancing the efficiency of the drug, nanotechnology was used. In the present study, several niosomal formulations of ART prepared using different molar ratios of Span 60 : Tween 60 : PEG-600: ART in PBS. These three formulations were FI (1:1:0.5:0.5), FII (2:1:0.5:0.5) and FIII (1:2:0.5:0.5), respectively. The encapsulation efficiency was measured by HPLC and the drug release was evaluated by dialysis method. The cytotoxicity test was determined by MTT assay. The size, zeta potential and polydispersity index of the vesicles was measured by Zeta Sizer. Stability study was performed within two months. The MTT assay results showed that cytotoxicity effect of these formulations on MCF-7 cell line is better than C6 cell line and the FIII had the best results for both of them. The entrapment efficiencies of the formulations I, II and III were obtained 82.2±1.88%, 75.5±0.92% and 95.5±1.23%, respectively. The results of size, zeta potential and polydispersity index indicated that the size of the vesicles is below 200 nm, their surface charge is about -35 mV and they were monodisperse. Stability and release study indicated that the formulation III has the best stability and release pattern. Therefore, the use of PEGylated niosomal ART can effectively improve its therapeutic index, stability and solubility.


2019 ◽  
Author(s):  
Antoine Maruani ◽  
Peter A. Szijj ◽  
Calise Bahou ◽  
João C. F. Nogueira ◽  
Stephen Caddick ◽  
...  

<p>Diseases are multifactorial, with redundancies and synergies between various pathways. However, most of the antibody-based therapeutics in clinical trials and on the market interact with only one target thus limiting their efficacy. The targeting of multiple epitopes could improve the therapeutic index of treatment and counteract mechanisms of resistance. To this effect, a new class of therapeutics emerged: bispecific antibodies.</p><p>Bispecific formation using chemical methods is rare and low yielding and/or requires a large excess of one of the two proteins to avoid homodimerisation. In order for chemically prepared bispecifics to deliver their full potential, high-yielding, modular and reliable cross-linking technologies are required. Herein, we describe a novel approach not only for the rapid and high-yielding chemical generation of bispecific antibodies from native antibody fragments, but also for the site-specific dual functionalisation of the resulting bioconjugates. Based on orthogonal clickable functional groups, this strategy enables the assembly of functionalised bispecifics with controlled loading in a modular and convergent manner.</p>


2018 ◽  
Author(s):  
Stacy A. Malaker ◽  
Kayvon Pedram ◽  
Michael J. Ferracane ◽  
Elliot C. Woods ◽  
Jessica Kramer ◽  
...  

<div> <div> <div> <p>Mucins are a class of highly O-glycosylated proteins that are ubiquitously expressed on cellular surfaces and are important for human health, especially in the context of carcinomas. However, the molecular mechanisms by which aberrant mucin structures lead to tumor progression and immune evasion have been slow to come to light, in part because methods for selective mucin degradation are lacking. Here we employ high resolution mass spectrometry, polymer synthesis, and computational peptide docking to demonstrate that a bacterial protease, called StcE, cleaves mucin domains by recognizing a discrete peptide-, glycan-, and secondary structure- based motif. We exploited StcE’s unique properties to map glycosylation sites and structures of purified and recombinant human mucins by mass spectrometry. As well, we found that StcE will digest cancer-associated mucins from cultured cells and from ovarian cancer patient-derived ascites fluid. Finally, using StcE we discovered that Siglec-7, a glyco-immune checkpoint receptor, specifically binds sialomucins as biological ligands, whereas the related Siglec-9 receptor does not. Mucin-specific proteolysis, as exemplified by StcE, is therefore a powerful tool for the study of glycoprotein structure and function and for deorphanizing mucin-binding receptors. </p> </div> </div> </div>


Sign in / Sign up

Export Citation Format

Share Document